Literature DB >> 33407897

Sporadic multiple meningiomas harbor distinct driver mutations.

Tareq A Juratli1,2, Insa Prilop3, Felix C Saalfeld4, Sylvia Herold5,6,7, Matthias Meinhardt7, Carina Wenzel7, Silke Zeugner5,6,7, Daniela E Aust5,6,7, Fred G Barker8, Daniel P Cahill9,8, Priscilla K Brastianos10, Sandro Santagata11, Gabriele Schackert3, Thomas Pinzer3.   

Abstract

Entities:  

Year:  2021        PMID: 33407897      PMCID: PMC7789520          DOI: 10.1186/s40478-020-01113-2

Source DB:  PubMed          Journal:  Acta Neuropathol Commun        ISSN: 2051-5960            Impact factor:   7.801


× No keyword cloud information.
  21 in total

1.  Management of multiple meningiomas.

Authors:  Georgios Tsermoulas; Mazda K Turel; Jared T Wilcox; David Shultz; Richard Farb; Gelareh Zadeh; Mark Bernstein
Journal:  J Neurosurg       Date:  2017-07-21       Impact factor: 5.115

Review 2.  Natural history of intraventricular meningiomas: systematic review.

Authors:  Benedito Jamilson Araújo Pereira; Antônio Nogueira de Almeida; Wellingson Silva Paiva; Paulo Henrique Pires de Aguiar; Manoel Jacobsen Teixeira; Suely Kazue Nagahashi Marie
Journal:  Neurosurg Rev       Date:  2018-08-15       Impact factor: 3.042

3.  Multiple meningiomas: differential involvement of the NF2 gene in children and adults.

Authors:  D G R Evans; C Watson; A King; A J Wallace; M E Baser
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

4.  Clonality of multiple meningiomas.

Authors:  A P Stangl; R Wellenreuther; D Lenartz; J A Kraus; A G Menon; J Schramm; O D Wiestler; A von Deimling
Journal:  J Neurosurg       Date:  1997-05       Impact factor: 5.115

5.  Multiple meningiomas: does quantity matter? a population-based survival analysis with underlined age and sex differences.

Authors:  Andres Ramos-Fresnedo; Ricardo A Domingo; Tito Vivas-Buitrago; Larry Lundy; Daniel M Trifiletti; Mark E Jentoft; Amit B Desai; Alfredo Quiñones-Hinojosa
Journal:  J Neurooncol       Date:  2020-09-28       Impact factor: 4.130

6.  Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22.

Authors:  G A Rouleau; W Wertelecki; J L Haines; W J Hobbs; J A Trofatter; B R Seizinger; R L Martuza; D W Superneau; P M Conneally; J F Gusella
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

7.  Incidental meningiomas in autopsy study.

Authors:  S Nakasu; A Hirano; T Shimura; J F Llena
Journal:  Surg Neurol       Date:  1987-04

8.  Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.

Authors:  Malak Abedalthagafi; Wenya Linda Bi; Ayal A Aizer; Parker H Merrill; Ryan Brewster; Pankaj K Agarwalla; Marc L Listewnik; Dora Dias-Santagata; Aaron R Thorner; Paul Van Hummelen; Priscilla K Brastianos; David A Reardon; Patrick Y Wen; Ossama Al-Mefty; Shakti H Ramkissoon; Rebecca D Folkerth; Keith L Ligon; Azra H Ligon; Brian M Alexander; Ian F Dunn; Rameen Beroukhim; Sandro Santagata
Journal:  Neuro Oncol       Date:  2016-01-28       Impact factor: 12.300

9.  Genomic landscape of high-grade meningiomas.

Authors:  Wenya Linda Bi; Noah F Greenwald; Malak Abedalthagafi; Jeremiah Wala; Will J Gibson; Pankaj K Agarwalla; Peleg Horowitz; Steven E Schumacher; Ekaterina Esaulova; Yu Mei; Aaron Chevalier; Matthew Ducar; Aaron R Thorner; Paul van Hummelen; Anat Stemmer-Rachamimov; Maksym Artyomov; Ossama Al-Mefty; Gavin P Dunn; Sandro Santagata; Ian F Dunn; Rameen Beroukhim
Journal:  NPJ Genom Med       Date:  2017-04-26       Impact factor: 8.617

10.  Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.

Authors:  Priscilla K Brastianos; Peleg M Horowitz; Sandro Santagata; Robert T Jones; Aaron McKenna; Gad Getz; Keith L Ligon; Emanuele Palescandolo; Paul Van Hummelen; Matthew D Ducar; Alina Raza; Ashwini Sunkavalli; Laura E Macconaill; Anat O Stemmer-Rachamimov; David N Louis; William C Hahn; Ian F Dunn; Rameen Beroukhim
Journal:  Nat Genet       Date:  2013-01-20       Impact factor: 38.330

View more
  3 in total

1.  Genomic profiling of sporadic multiple meningiomas.

Authors:  E Zeynep Erson-Omay; Shaurey Vetsa; Sagar Vasandani; Tanyeri Barak; Arushii Nadar; Neelan J Marianayagam; Kanat Yalcin; Danielle Miyagishima; Stephanie Marie Aguilera; Stephanie Robert; Ketu Mishra-Gorur; Robert K Fulbright; Declan McGuone; Murat Günel; Jennifer Moliterno
Journal:  BMC Med Genomics       Date:  2022-05-14       Impact factor: 3.622

Review 2.  Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?

Authors:  Alessia Pellerino; Francesco Bruno; Rosa Palmiero; Edoardo Pronello; Luca Bertero; Riccardo Soffietti; Roberta Rudà
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

3.  Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord.

Authors:  Lingyang Hua; Majd Alkhatib; Dino Podlesek; Leila Günther; Thomas Pinzer; Matthias Meinhardt; Silke Zeugner; Sylvia Herold; Daniel P Cahill; Priscilla K Brastianos; Erik A Williams; Victoria E Clark; Ganesh M Shankar; Hiroaki Wakimoto; Leihao Ren; Jiawei Chen; Ye Gong; Gabriele Schackert; Tareq A Juratli
Journal:  Acta Neuropathol       Date:  2022-08-09       Impact factor: 15.887

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.